Avista Public II (AHPAU) Prices $200M IPO

Avista Public Acquisition Corp. II announced the pricing of its $200 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “AHPAU”, Tuesday, August 10.

The new company intends to combine with a target in the healthcare industry that has a strong management team, stable cash flows and robust growth prospects. Avista Public II is led by Executive Chairman Thompson Dean, President and CEO David Burgstahler, EVPs Sriram Venkataraman and Robert Girardi, IRO Amanda Heravi, CFO John Cafasso, and General Counsel Benjamin Silbert.

Total SPAC deal count for 2021 year-to-date is now 397. This offering is expected to close on Thursday, August 12.

Credit Suisse Securities (USA) LLC is the sole book-running manager for the offering. Weil, Gotshal & Manges LLP is serving as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.